Generic Portal

— Research Explorer

A phase I/II study of bevacizumab, irinotecan and erlotinib in children with progressive diffuse intrinsic pontine glioma

Research output: Contribution to journal › Article › Academic › peer-review

DOI

https://doi.org/10.1007/s11060-021-03763-1
Final published version

Fatma E. el-Khouly
Sophie E. M. Veldhuijzen van Zanten
Marc H. A. Jansen
Dewi P. Bakker
Esther Sanchez Aliaga
N. Harry Hendrikse
W. Peter Vandertop
Dannis G. van Vuurden
Gertjan J. L. Kaspers

Original language	English
Pages (from-to)	263-271
Number of pages	9
Journal	Journal of neuro-oncology
Volume	153
Issue number	2
Early online date	2021
DOIs	https://doi.org/10.1007/s11060-021-03763-1
Publication status	Published - Jun 2021

Research areas

Bevacizumab, Diffuse intrinsic pontine glioma (DIPG), Erlotinib, Irinotecan, Targeted therapy

ID: 18251088